TransMedics Group, Inc. (BIT:1TMDX)
Italy · Delayed Price · Currency is EUR 116.60
+12.65 (12.17%)
At close: Oct 30, 2025
TransMedics Group Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| 566.35 | 441.54 | 241.62 | 93.46 | 30.26 | 25.64 | Upgrade | |
Revenue Growth (YoY) | 41.20% | 82.74% | 158.53% | 208.83% | 18.03% | 8.62% | Upgrade |
Cost of Revenue | 224.95 | 179.46 | 87.53 | 28.19 | 9.1 | 9 | Upgrade |
Gross Profit | 341.41 | 262.08 | 154.09 | 65.27 | 21.16 | 16.64 | Upgrade |
Selling, General & Admin | 180.63 | 168.62 | 117.55 | 69.9 | 38.28 | 24.19 | Upgrade |
Research & Development | 64.82 | 55.97 | 36.06 | 26.81 | 22.3 | 18.83 | Upgrade |
Operating Expenses | 245.45 | 224.59 | 153.61 | 96.71 | 60.59 | 43.02 | Upgrade |
Operating Income | 95.95 | 37.5 | 0.49 | -31.44 | -39.43 | -26.38 | Upgrade |
Interest Expense | -14 | -14.41 | -10.79 | -3.73 | -3.87 | -3.99 | Upgrade |
Interest & Investment Income | 11 | 13.4 | 12.5 | - | - | - | Upgrade |
Currency Exchange Gain (Loss) | 1.4 | 0.7 | 0.3 | - | -1 | 1 | Upgrade |
Other Non Operating Income (Expenses) | -1.48 | -1.41 | 0.05 | -0.43 | 0.12 | 0.65 | Upgrade |
EBT Excluding Unusual Items | 92.88 | 35.78 | 2.54 | -35.59 | -44.18 | -28.72 | Upgrade |
Merger & Restructuring Charges | - | - | -2 | - | - | - | Upgrade |
Other Unusual Items | - | - | - | -0.58 | - | - | Upgrade |
Pretax Income | 92.88 | 35.78 | -26.67 | -36.17 | -44.18 | -28.72 | Upgrade |
Income Tax Expense | 1.11 | 0.32 | -1.64 | 0.07 | 0.04 | 0.03 | Upgrade |
Net Income | 91.77 | 35.46 | -25.03 | -36.23 | -44.22 | -28.75 | Upgrade |
Net Income to Common | 91.77 | 35.46 | -25.03 | -36.23 | -44.22 | -28.75 | Upgrade |
Shares Outstanding (Basic) | 34 | 33 | 33 | 30 | 28 | 25 | Upgrade |
Shares Outstanding (Diluted) | 39 | 35 | 33 | 30 | 28 | 25 | Upgrade |
Shares Change (YoY) | 13.12% | 8.30% | 10.02% | 7.02% | 11.80% | 73.91% | Upgrade |
EPS (Basic) | 2.71 | 1.07 | -0.77 | -1.23 | -1.60 | -1.16 | Upgrade |
EPS (Diluted) | 2.54 | 1.01 | -0.77 | -1.23 | -1.60 | -1.16 | Upgrade |
Free Cash Flow | 120.65 | -80.94 | -164.88 | -57.72 | -32.38 | -30.72 | Upgrade |
Free Cash Flow Per Share | 3.08 | -2.30 | -5.07 | -1.95 | -1.17 | -1.24 | Upgrade |
Gross Margin | 60.28% | 59.36% | 63.77% | 69.84% | 69.92% | 64.88% | Upgrade |
Operating Margin | 16.94% | 8.49% | 0.20% | -33.64% | -130.29% | -102.91% | Upgrade |
Profit Margin | 16.20% | 8.03% | -10.36% | -38.77% | -146.11% | -112.13% | Upgrade |
Free Cash Flow Margin | 21.30% | -18.33% | -68.24% | -61.76% | -107.01% | -119.82% | Upgrade |
EBITDA | 120.55 | 57.25 | 8.66 | -27.96 | -37.61 | -24.81 | Upgrade |
EBITDA Margin | 21.29% | 12.97% | 3.58% | -29.92% | -124.28% | -96.75% | Upgrade |
D&A For EBITDA | 24.6 | 19.76 | 8.18 | 3.48 | 1.82 | 1.58 | Upgrade |
EBIT | 95.95 | 37.5 | 0.49 | -31.44 | -39.43 | -26.38 | Upgrade |
EBIT Margin | 16.94% | 8.49% | 0.20% | -33.64% | -130.29% | -102.91% | Upgrade |
Effective Tax Rate | 1.20% | 0.88% | - | - | - | - | Upgrade |
Revenue as Reported | 566.35 | 441.54 | 241.62 | 93.46 | 30.26 | 25.64 | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.